Highlights

New cancer care institute launched in Manesar. Advanced treatments and technologies on offer. Emphasis on personalized, precision oncology.

Latest news

Optimized Electrotech raises Rs.35 Crore in round led by Exfinity ventures to power its expansion into space-based imaging

Optimized Electrotech raises Rs.35 Crore in round led by Exfinity ventures to power its expansion into space-based imaging

Goldman Sachs sees Paytm growth engine accelerating; market share gains to drive 26% GMV growth

Goldman Sachs sees Paytm growth engine accelerating; market share gains to drive 26% GMV growth

Fabpad Surpasses 12-Month Projections in 90 Days, Delivers 300% Growth Following Seed Round

Fabpad Surpasses 12-Month Projections in 90 Days, Delivers 300% Growth Following Seed Round

South Korean market cap surpasses 6,000 trillion won for first time

South Korean market cap surpasses 6,000 trillion won for first time

India ITME Society Leads First-Ever Textile Trade Business Delegation to Indonesia

India ITME Society Leads First-Ever Textile Trade Business Delegation to Indonesia

'Golmaal 5' cast reunites for Ooty shoot schedule

'Golmaal 5' cast reunites for Ooty shoot schedule

India-NZ FTA seen boosting textile exports, aiding USD 350 bn sector target: CITI

India-NZ FTA seen boosting textile exports, aiding USD 350 bn sector target: CITI

PM Modi meets NITI Aayog's new full-time member Dr Gobardhan Das, calls his journey 'very inspiring'

PM Modi meets NITI Aayog's new full-time member Dr Gobardhan Das, calls his journey 'very inspiring'

Fortis Hospital Manesar Launches "Fortis Cancer Institute" - Region's First Dedicated Cancer Institute, Redefining Technology-Driven Oncology Care

Fortis Manesar launches its first cancer institute, featuring advanced treatment technologies and a patient-centric approach, offering comprehensive cancer care.

Fortis Hospital Manesar Launches "Fortis Cancer Institute" - Region's First Dedicated Cancer Institute, Redefining Technology-Driven Oncology Care

NewsVoir
Manesar (Haryana) [India], April 27: Fortis Hospital Manesar, today launched Fortis Cancer Institute, the first dedicated cancer institute in Manesar, marking a significant leap in technology and precision led cancer care. The Fortis Cancer Institute at Manesar brings together a wide spectrum of next-generation cancer treatment technologies and specialised interventions under one integrated platform - designed to deliver comprehensive, personalised, and outcomes-driven cancer care.
Fortis Cancer Institute, Manesar is backed by the latest healthcare infrastructure which includes Da Vinci Xi robotic surgery system, HIPEC (Hyperthermic Intraperitoneal Chemotherapy), PIPAC (Pressurized Intraperitoneal Aerosolized Chemotherapy), HAIP (Hepatic Artery Infusion Pump) chemotherapy, fluorescence-guided breast surgery, oncoplastic breast surgery, a dedicated lymphedema clinic, and organ-specific oncology programmes designed to deliver highly personalised treatment. The institute also places strong emphasis on precision oncology, supported by a multi-disciplinary tumor board, alongside newer treatment approaches such as immunotherapy, targeted therapy, molecular oncology, and genetic counseling and testing, enabling more tailored treatment decisions for complex cancer cases.
Speaking at the launch, Dr. Vinay Samuel Gaikwad, Senior Director, Surgical Oncology, Fortis Hospital, Manesar said, "The future of oncology lies in combining surgical precision with personalised treatment pathways. At Fortis Cancer Institute, our focus is on using advanced technologies to make cancer treatment more targeted, less invasive, and more effective for every patient."
Dr. Pooja Babbar, Consultant, Medical Oncology, Fortis Hospital, Manesar said, "Cancer care today is no longer defined by a single treatment approach. By integrating molecular diagnostics, targeted therapies, and collaborative decision-making, we are creating a more comprehensive model of care that can improve both outcomes and quality of life."
Dr. Mansi Chowhan, Senior Consultant, Surgical Oncology, Fortis Hospital, Manesar said, "What makes modern oncology different is the ability to treat each cancer uniquely. Through genetic testing, immunotherapy, and organ-specific expertise, we are able to design treatment strategies that are far more precise than conventional care."
Abhijit Singh, Facility Director, Fortis Hospital Manesar, said, "The launch of the Fortis Cancer Institute at Manesar marks a significant step in our mission to bring world-class, advanced cancer care closer to patients in Manesar and surrounding regions. At a time when cancer cases are rising globally, there remains a critical gap in accessible, high-quality treatment. Fortis Cancer Institute, Manesar is designed to bridge this need, delivering cutting-edge technology, multidisciplinary expertise, and some of the finest oncologists to ensure comprehensive, patient-centric care."
About Fortis Healthcare Limited
Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and day care specialty facilities. Currently, the company operates 36 healthcare facilities (including JVs and O&M facilities) across 12 states and union territories. The Company's network comprises over 6,000 operational beds (including O&M beds) and 400 diagnostics labs.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by NewsVoir. ANI will not be responsible in any way for the content of the same.)

(This article was generated from news agency ANI without modifications to the text.)

ADVERTISEMENT

Up Next

Fortis Hospital Manesar Launches "Fortis Cancer Institute" - Region's First Dedicated Cancer Institute, Redefining Technology-Driven Oncology Care

Fortis Hospital Manesar Launches "Fortis Cancer Institute" - Region's First Dedicated Cancer Institute, Redefining Technology-Driven Oncology Care

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Reliance denies buying Iranian oil amid US sanctions waiver

Reliance denies buying Iranian oil amid US sanctions waiver

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

Govt announces seven measures to help boost exports

Govt announces seven measures to help boost exports

ADVERTISEMENT

editorji-whatsApp

More videos

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI pauses rate cuts, retains interest rate at 5.25 pc

RBI pauses rate cuts, retains interest rate at 5.25 pc

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

Explained: India-US trade deal, tariffs and trade benefits

Explained: India-US trade deal, tariffs and trade benefits

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.